April 10, 2025 • Recall #25223
Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging
Recall Description
This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
Hazards Identified
- The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
Consumer Remedy
- Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
Affected Products
| Product Name | Type | Units Affected |
|---|---|---|
| Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs | N/A | About 14,250 |
Recalled Safetussin Max Strength Multi-Symptom Cough, Cold and Flu, 24-count caplets
ManufacturersNot specified
Retailers
HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.
Verify Official Notice
Product recall terms or points of contact can change. Verify instructions directly with the CPSC announcement page.
View Official CPSC Notice